Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Pool Advista Indonesia Tbk. (POOL) vs Tempo Scan Pacific Tbk. (TSPC)

Pool Advista Indonesia Tbk.Trading
Tempo Scan Pacific Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Pool Advista Indonesia Tbk. dan Tempo Scan Pacific Tbk.: Pool Advista Indonesia Tbk. diperdagangkan di Rp50 (kapitalisasi pasar 117,07 M), sedangkan Tempo Scan Pacific Tbk. diperdagangkan di Rp2.730 (kapitalisasi pasar 12,36 T, volume 24 jam 1,41 jt). Perbedaan utamanya: Tempo Scan Pacific Tbk. jauh lebih besar — sekitar 105,6× kapitalisasi pasar Pool Advista Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.

POOLTSPC
Kapitalisasi Pasar
117,07 M12,36 T
Volume
1,41 jt
Lot
14,08 rb
Perputaran
3,83 M
Harga Rata-rata
2.722,04
Nilai Transaksi
3,83 M
Harga Ekuilibrium Indikatif
2.730
Volume Ekuilibrium Indikatif
2,51 rb

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

POOL
Lihat detail
TSPC
Lihat detail

Tentang Pool Advista Indonesia Tbk.

PT Pool Advista Indonesia Tbk (formerly PT. Pool Asuransi Indonesia Tbk) was established on August 16, 1958 based on the notarial deed of Meester Liem Hie Thaij No.86, the changes of notarial of Anwar Mahajudin. The notarial deed was approved by the Ministry of Justice in his decision letter No.J.A5/104/10 dated December 1, 1958 and was published on State Gazette No. 55, Supplement No. 332 dated July 11, 1961. The Company has branches in Medan, Pekanbaru, Bandar Lampung, Bogor, Cirebon, Surabaya and Samarinda.

Selengkapnya di halaman POOL

Tentang Tempo Scan Pacific Tbk.

PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.

Selengkapnya di halaman TSPC